Neural Therapeutics Inc. (NURL.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 07/31
(Values in thousands)
| 07-2025 | 07-2024 | 07-2023 | 07-2022 | 07-2021 | |
| Cash Flows From Operating Activities | |||||
| Accounts receivable | 21 | 42 | -19 | -51 | N/A |
| Accounts payable and accrued liabilities | -65 | 17 | 415 | 223 | N/A |
| Other Working Capital | 184 | 299 | 560 | 141 | 270 |
| Other Operating Activity | -456 | -678 | -1,484 | -915 | -390 |
| Operating Cash Flow | $-315 | $-320 | $-527 | $-602 | $-120 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 465 | 115 | 428 | 792 | N/A |
| Other Financing Activity | -51 | -2 | 0 | 181 | -1,029 |
| Financing Cash Flow | $414 | $113 | $428 | $973 | $-1,029 |
| Beginning Cash Position | 67 | 273 | 372 | 0 | 1,149 |
| End Cash Position | 165 | 67 | 273 | 372 | 0 |
| Net Cash Flow | $99 | $-207 | $-99 | $372 | $-1,149 |
| Free Cash Flow | |||||
| Operating Cash Flow | -315 | -320 | -527 | -602 | -120 |
| Free Cash Flow | -315 | -320 | -527 | -602 | -120 |